Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
VITISIN B
ID: ALA2230305
Max Phase: Preclinical
Molecular Formula: C56H42O12
Molecular Weight: 906.94
Molecule Type: Small molecule
Associated Items:
ID: ALA2230305
Max Phase: Preclinical
Molecular Formula: C56H42O12
Molecular Weight: 906.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1ccc([C@H]2Oc3cc(O)cc(/C=C/c4ccc5c(c4)[C@@H](c4cc(O)cc6c4[C@H](c4cc(O)cc(O)c4)[C@@H](c4ccc(O)cc4)O6)[C@H](c4ccc(O)cc4)O5)c3[C@@H]2c2cc(O)cc(O)c2)cc1
Standard InChI: InChI=1S/C56H42O12/c57-35-10-4-29(5-11-35)54-50(33-19-38(60)23-39(61)20-33)49-32(18-42(64)26-47(49)67-54)3-1-28-2-16-46-44(17-28)52(56(66-46)31-8-14-37(59)15-9-31)45-25-43(65)27-48-53(45)51(34-21-40(62)24-41(63)22-34)55(68-48)30-6-12-36(58)13-7-30/h1-27,50-52,54-65H/b3-1+/t50-,51-,52-,54+,55+,56-/m0/s1
Standard InChI Key: WZKKRZSJTLGPHH-QGYUWUKLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 906.94 | Molecular Weight (Monoisotopic): 906.2676 | AlogP: 11.00 | #Rotatable Bonds: 8 |
Polar Surface Area: 209.76 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 9 |
#RO5 Violations: 4 | HBA (Lipinski): 12 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 8.58 | CX Basic pKa: | CX LogP: 11.08 | CX LogD: 11.04 |
Aromatic Rings: 8 | Heavy Atoms: 68 | QED Weighted: 0.07 | Np Likeness Score: 0.87 |
1. Lambert C, Bisson J, Waffo-Téguo P, Papastamoulis Y, Richard T, Corio-Costet MF, Mérillon JM, Cluzet S.. (2012) Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family., 60 (48): [PMID:23145924] [10.1021/jf303290g] |
2. Lee JH, Kim YG, Ryu SY, Cho MH, Lee J.. (2014) Resveratrol oligomers inhibit biofilm formation of Escherichia coli O157:H7 and Pseudomonas aeruginosa., 77 (1): [PMID:24456071] [10.1021/np400756g] |
Source(1):